ArticleCurrent microbiology2025
Unveiling the Metabolites and Biological Characteristics of Swampomyces armeniacus from Red Sea Mangroves Ecosystems.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obligate marine fungi associated with mangroves are a unique group that fulfils significant ecological functions in mangrove ecosystems. The present study aimed to assess the antimicrobial, antioxidant, and anticancer potentials of the marine fungus "Swampomyces armeniacus" isolated and characterized (on both morphological and molecular levels) from mangroves located in RAS Mohamed natural protectorate on the Red Sea coast; along with determining the metabolomics profiling of the candidate species. The antimicrobial capability was assessed via the agar well diffusion method against 6 strains (Bacillus cereus, Staphylococcus aureus, Shigella sonnei, Pseudomonas aeruginosa, Candida albicans, and Aspergillus niger) alongside determining the minimum inhibitory concentration (MIC) by two-fold microdilution method. The study findings indicated that S. armeniacus crude extract had antimicrobial activity against all test strains whereas the strongest effect was against B. cereus with MIC value 0.7 μg/ml. Moreover, the antioxidant potential was determined via DPPH which showed strong radical scavenging activity of 88.3% and IC50 = 20.4 μg/mL. Additionally, the extract exhibited significant anticancer activity against A549 lung cancer cells, with an IC50 value of 15.57 ± 0.27 µg/mL, while showing minimal toxicity toward normal Wi38 cells (IC50 = 37.71 ± 0.31 µg/mL). GC-MS investigation of S. armeniacus crude extract exhibiting antimicrobial, antioxidant, and anticancer related bioactive compounds such as (Di-tert-butylhydroquinone, 4-Aminocyclohexanecarboxylic acid) and various fatty acids namely (stearic acid, palmitic acid, Ethanedioic acid, and Butanedioic acid). These results highlight the biological activity of S. armeniacus and emphasizing its potential as a unique source of bioactive molecules for biotechnological and therapeutic applications.
Indexed as
Identifiers
41085656What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.